The Prelude Connect App is now available for all patients! Prelude Connect App
The Prelude Connect App is now available for all patients! Prelude Connect App
At PCRM, we understand that a cancer diagnosis can bring immense emotional and physical challenges, especially when it comes to preserving your fertility while undergoing lifesaving treatments. That’s why we proudly offer comprehensive oncofertility services, a specialized branch of fertility medicine that focuses on preserving the reproductive potential of cancer patients.
PCRM offers a comprehensive oncofertility program led by Dr. Jeff Roberts, who received special training during his fellowship at New York’s Cornell Medical Center, where the first human ovarian transplant was performed, and many of the commonly employed fertility-sparing techniques pioneered. Supported by a staff with over 15 years of experience with cryopreservation, the PCRM laboratory has the instrumentation and technical expertise required to conduct the techniques of egg, embryo, sperm, and ovarian tissue cryopreservation. We also subsidize oncofertility services for eligible patients and work with pharmaceutical companies to supply medication.
Although modern medical therapies for cancer have become immensely successful, the price paid for survival is often the loss of reproductive function. Using assisted reproductive technologies, including cryopreservation and in vitro fertilization (IVF), we are able to provide our patients with hope for their future family-building plans.
To be eligible for oncofertility and cancer fertility preservation, female patients must have the following criteria:
Apply for our Cost Reduction Program
To be eligible for oncofertility and cancer fertility preservation, male patients must have the following criteria:
Oncofertility atients are financially responsible for:
Cryopreservation storage fees for eggs, embryos, and sperm, as well as any fees related to the utilization of the eggs and embryos for future treatments at 50% off. The standard storage rate will apply after the first year. Medications not provided by PCRM Fertility Preservation Foundation and our participating vendors will be provided “at cost” (no markup) through the PCRM Fertility Medication Dispensary. These costs uncommonly exceed $1000 and depend on the availability of compassionate products.
In partnership with Fertile Future, PCRM will subsidize cryopreservation (banking) of eggs, embryos, or sperm at our facility. Medication may be provided by PCRM Fertility Preservation Foundation; however, the availability of the product is variable. Three of our pharmaceutical vendors, EMD Serono Canada, Organon Canada, and Ferring Canada, may provide us with compassionate medication on request.
Fertility Preservation CFAS Guidelines
Fertile Future is a Canadian non-profit organization dedicated to providing fertility preservation information and support to cancer patients and oncology health care providers. PCRM’s very own Dr. Roberts serves as the President of this exceptional organization. For more information, please visit their website or read the Fertile Future Power of Hope Brochure.
Facing cancer is a battle no one should fight alone, and we are dedicated to providing compassionate and personalized care to help you navigate the complex intersection of cancer treatment and fertility preservation. If you have any questions regarding your treatment or the PCRM Fertility Preservation Program please feel free to contact Dr. Jeffrey Roberts through the clinic at 604-422-7276 or directly by email: jroberts@pacificfertility.ca.
